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Abstract
This chapter reviews the differences in specific structural and functional characteris‐
tics of human visual cortex among young adults, healthy aging adults, and patients with
dementia, with a primary focus on those with Alzheimer’s disease (AD). Such visual
cortex changes have been shown to underlie many of the behavioral deficits that develop
in  healthy  aging  and AD.  Measurements  of  disordered visual  cortex  in  dementia
patients may be possible early in the course of neurodegeneration and thus may be
useful for improving early diagnosis of these devastating diseases.
Keywords: visual cortex, visual field mapping, dementia, healthy aging, functional
neuroimaging
1. Introduction
1.1. Overview of visual cortex characteristics
Human visual cortex can be partitioned into distinct topographical representations of visual
space called visual field maps (VFMs), each of which subserves separate perceptual functions
spanning the hierarchical stages of visual processing [1–3]. The organization of a VFM fol‐
lows the organization of the retina; hence, retinotopic VFMs are cortical regions in which nearby
neurons analyze the properties of nearby points of an image on the retina, and thus of visual
space. This VFM organization is one of the more important, larger-scale, organizing princi‐
ples of visual cortex. Such topographic organization is thought to allow for efficient connectiv‐
ity among neurons that represent nearby aspects of visual space, likely necessary for such
processes as lateral inhibition and to compactly organize neural signals ranging from the
molecular level to that of the cerebral hemisphere [4–7]. In addition, measurements of the
characteristics of these VFMs, together with an understanding of the stimulus selectivity of the
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neurons within them, is the foundation for understanding the specific visual computations
carried out in particular cortical regions. Not only are such in vivo measurements of VFMs
essential for the study of visual processing in healthy subjects, but they also are very effective
for tracking changes in visual cortex in response to changes in visual inputs such as those that
arise from retinal or cortical damage [8–12].
Although historically the organization and function of visual cortex have been primarily well
characterized in healthy young adults or young patient populations [1–3, 8, 12–16], many
behavioral studies [17–38] and more recent neuroimaging studies [36, 37, 39–55] are suggesting
that several changes occur within visual pathways during what is considered otherwise
healthy aging. These studies specifically describe retinal and cortical changes, rather than
optical changes in the eye, that primarily contribute to the decreases in visual acuity and related
issues that have been measured in healthy aging subjects [19, 33, 46, 50, 54]. These healthy
aging changes are also now starting to be compared to pathophysiological changes in visual
cortex in age-related disorders like dementia, including diseases such as Alzheimer’s disease
(AD), posterior cortical atrophy (PCA), and dementia with Lewy bodies (DLB), in the hopes
of both improving our understanding of these diseases and aiding improvements in potential
therapies [37, 56].
Visual deficits are reported surprisingly often as one of the first symptoms of AD, the most
common form of dementia. These deficits can include problems with visual-spatial attention,
visual-spatial tasks, and visual-processing speed [37, 40, 47, 57–75]. A subset of dementia
patients presents with prominent visual symptoms such as problems with visual field defects,
contrast sensitivity, color discrimination, and feature recognition of complex objects, but little
initial decline in memory. These patients have increased neuropathology in visual cortex, as
compared to typical AD patients [76–84]. Dementia with these characteristics was initially
often referred to as visual variant AD, but it is now usually termed PCA. DLB, the second most
common type of dementia, also often presents with visual complaints [85]. Like in AD and
PCA, the central features of DLB include progressive cognitive decline, typically with impair‐
ments in memory, visual-spatial abilities, and attention. However, unlike AD and PCA, one
of the earliest visual symptoms in this disease is commonly visual hallucination [86].
Early detection and accurate diagnosis are keys in the hope for a cure for such dementias, as
early, precise diagnosis would allow for more timely initiation of treatments. As visual
symptoms can occur early in these diseases, studies are beginning to demonstrate that
measurements of related changes in visual cortex in these patients could aid early detection
of neurodegeneration. The highly structured representations within VFMs afford a funda‐
mental measurement that might be used to detect subtle effects of neurodegeneration early in
the disease process. Clear measures of the progression of the pathology within visual cortex
might also help to target drug research for therapeutic interventions, especially by differenti‐
ating among different types of dementia [62]. The information reviewed in this chapter will
serve as a foundation for subsequent use of this knowledge in our evaluation, interpreta‐
tion, and treatment of these diseases. As little has been studied regarding VFMs in patients
with PCA or DLB, this chapter will focus on measurements from patients with AD.
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1.2. Review methodology
We performed a systematic review to investigate whether there are changes in early VFMs V1,
V2, V3, and hV4 characteristics to healthy aging subjects and patients with AD or related
dementias that can be measured using functional magnetic resonance imaging (fMRI). In order
to include as many relevant citations as possible, we searched a comprehensive range of
scientific databases including CogPrints, FreeFullPDF, Google Scholar, IngentaConnect,
JSTOR, Mendeley, Microsoft Academic Search, PubMed, PubPsych, ResearchGate, and Web
of Science. In addition, the Google search engine was used to find institutional, professional,
and personal webpages hosting potentially relevant PDFs or citation links. Searches were
performed from November 2015, to May 2016. Search queries included the following terms in
various combinations: visual cortex, visual field map, visual area, primary visual cortex, V1,
V2, V3, hV4, occipital cortex, visual changes, fMRI, pRF modeling/modeling, neuroimaging,
aging, healthy aging, human, dementia, neurodegeneration, mild cognitive impairment,
Alzheimer’s disease, dementia with Lewy bodies, Lewy body dementia, and posterior cortical
atrophy. Related citation links available for the various database searches were routinely
evaluated to investigate additional potential citations of interest. All potential study designs
were included, and potentially relevant citations spanned the dates 1925–2016; note that visual
field mapping with fMRI was relatively recently introduction in 1994 [87].
Ultimately, 317 potentially relevant citations were downloaded to EndNote for further
evaluation. The full papers of these citations were assessed and selected to only include studies
that directly related to comparing fMRI measures of visual cortex or visual field maps in
healthy young adults (aged 18–40 years) to changes in visual cortex or visual field maps in
healthy aging subjects with no known age-related diseases or specific, clinically recognized
deficits in vision (aged 55–80 years) and/or to patients with mild-to-moderate AD with no
known visual deficits unrelated to dementia (aged 55–80 years). No studies of VFM changes
in DLB or PCA were found during the initial database searches, which was not unexpected
given the very recent emergence of interest in visual field mapping in dementia. Additional
studies of visual field mapping methodology and of visual symptoms associated with healthy
aging, AD, DLB, and PCA were also retained for methods discussion and hypothesis devel‐
opment, respectively. Studies were further evaluated for quality and were excluded if they
lacked statistical analysis or if they did not use accurate cortical field mapping techniques with
individual subject analysis (for further discussion of these criteria, see [1, 3, 88]).
Of the 317 downloaded studies, 165 papers were directly relevant to this review, of which 88
focused on visual changes in aging or dementia. Of these, 24 studies measured changes
specifically in visual cortex related to aging and/or dementia, and three studies explicitly
investigated VFM changes in aging and/or dementia, as appropriate with respect to the
inclusion and exclusion criteria [36, 37, 39]. Here, we provide both a narrative discussion of all
165 sources as well as graphical examples drawn from the three key visual field mapping
studies. We discuss what is known regarding changes in early visual cortex during healthy
aging and AD, how these findings relate to visual symptoms in these conditions, and what
remains to be studied, and we recommend directions for future research.
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2. The measurement and organization of visual cortex in healthy young
adults
In order to carefully evaluate alterations of visual cortex in healthy aging and age-related
neurodegenerative diseases such as AD, we must first have an accurate and detailed under‐
standing of the characteristics of visual cortex in healthy young adults. Visual cortex encom‐
passes nearly 20% of the human cortical sheet, and studies are demonstrating that nearly all
of it is organized into VFMs [1, 3]. Because many calculations are necessary to produce our
visual world, our brains have many specialized VFMs which perform one or more of those
calculations [3, 89]. Most—if not all—of these calculations are performed across the entire
visual scene; color perception, for example, occurs throughout the visual field, not just in the
lower right quadrant. Ultimately, it will be very interesting to investigate changes in visual
cortex among all levels of the cortical visual hierarchy, from low-level visual processing in
primary visual cortex (V1) to mid-level specialization like motion processing to higher-level
processing like face recognition and visual-spatial attention [2, 90]. For now, studies of
plasticity and neurodegeneration primarily investigate the lower level visual areas like V1, V2,
V3, and hV4, as these VFMs are particularly well established in healthy young adults, relatively
uncontroversial, and typically easily measured across most types of patients [1, 3, 8, 12, 14, 15,
37, 91].
Figure 1. Schematic of measurements of an individual voxel. (A) Within a typical voxel measured with a standardly
used 3T MRI scanner, there are on the order of ∼1 million neurons, depending on the size of the voxel. For voxels in
retinotopic visual cortex, the neurons each have similarly located spatial receptive fields (teal circles with black outlines)
with preferred centers (black dots). Note how the overlapping receptive fields concentrate coverage in one region of
visual space (darker teal) corresponding to the average receptive field of the group, as shown in (D). (B) Each typical
voxel is on the order of 1 × 1 × 1 mm for structural measurements and 1 × 1 × 3 mm for visual field mapping functional
experiments, though voxels are often slightly larger (e.g., 3 × 3 × 3 mm) for other types of functional MR studies. (C)
Traveling wave retinotopy (TWR) utilizes the organization of retinotopic cortex, in which neighboring neurons have
preferred centers (black dot) representing similar portions of visual space, to estimate the average preferred representa‐
tion (center) for the population of neurons in a given voxel (e.g., [1, 3]). (D) Population receptive field (pRF) modeling
similarly utilizes retinotopic organization to estimate not only the preferred center (black dot) in a given voxel, but also
the average receptive field—the population receptive field (teal circle)—for the voxel’s population of neurons (e.g., [1, 3,
92]).
2.1. Human visual field map measurements use simple stimuli and tasks, but provide
exquisite detail of cortical organization
We briefly review here two of the most powerful fMRI techniques for very detailed measure‐
ments of VFMs in individual subjects, traveling wave retinotopy (TWR) [87] and population
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receptive field (pRF) modeling [92], to demonstrate what types of measurements are possible
and how to interpret the existing literature regarding changes in aging or damaged visual
cortex (Figures 1–4).
Figure 2. Phase-encoded fMRI paradigm for visual field map measurements. (A) An example phase-encoded experi‐
mental design [87]. Top diagram shows the components of a single block of one stimulus presentation (teal) for one
position (i.e., stimulus phase) of an expanding ring stimulus composed of a black and white moving checkerboard pat‐
tern. Middle diagram shows six blocks (teal) grouped together into one stimulus cycle (purple). The progressively larg‐
er ring stimulus is shown above each block. Each block in one cycle presents a specific stimulus in the “phase-
encoded”—or “traveling wave”—sequence. Each cycle then repeats the same set of blocks. Lower diagram shows a
full, single scan comprising six cycles; each cycle is one purple block. (B) Schematic diagram of three example phase-
encoded time series with different stimulus responses. Each row depicts the time series measurement for a single voxel
arising from a single, six-cycle scan using one experimental stimulus (e.g., polar angle). Simulated raw data points
showing percent blood-oxygen-level-dependent (BOLD) modulation (i.e., response amplitude) are denoted by the
black dots. The teal dotted lines represent sinusoidal fits of the simulated data points; each teal line characterizes the
average BOLD activation in a different example voxel. The red lines indicate the peak activations per cycle for this
imaginary set of voxels. Top and middle rows represent time series of voxels with the same %BOLD modulation, but
different timing of peak responses, which indicates different stimulus selectivity (i.e., responses to different “phases”
of the stimulus). Note the offset of the red lines between the two rows. For example, the top row might represent a
voxel with a preferred eccentricity tuning of 2° eccentric to fixation, whereas the middle row might have a preferred
tuning of 5° eccentric to fixation. Middle and bottom rows represent time series of voxels with the same timing of peak
responses, indicating matching stimulus selectivity; i.e., both might have a preferred eccentricity tuning of 5° eccentric
to fixation. However, the bottom row has much lower %BOLD modulation than the middle row. Such a difference in
response amplitude can be due to several factors, such as differences in local vasculature or receptive field tuning. (C)
Diagram of three example Fourier power spectra corresponding to the schematic time series in (B). In the phase-encod‐
ed paradigm, only BOLD responses that match the stimulus frequency of six cycles per scan (red peak) are considered
as data. The responses must also be above a predetermined statistical threshold, typically measured in coherence or
percentage variance explained [3, 87, 92]. (D) Diagram of three example averaged stimulus cycles corresponding to the
schematic Fourier spectra in (C) and to averages of the time series in (B). Each teal dotted line represents the sinusoidal
fit for the average, while the peak activation is again marked by the red line. The timing of the peak of each averaged
cycle is used to calculate the phase of the preferred stimulus independently for each voxel. Typical pseudocolor over‐
lays on 3D or flattened brain renderings as shown in Figures 6 and 12 use color to denote cortical responses to this
peak activation. Note how the top measurement has an earlier peak (red line) that corresponds to an earlier phase of the
stimulus (i.e., an earlier presentation time in the cycle) while the middle and bottom measurements’ peaks are shifted
to later in time (e.g., [3]). The bottom example has a lower %BOLD modulation than the other two schematics, but the
same peak activation as the middle example. For additional discussion, see [1, 3, 87, 91, 92].
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Figure 3. Population receptive field modeling. The parameter estimation procedure for the population receptive field
(pRF) model is shown as a flow chart [92]. The pRF parameters are estimated from time series measurements using a
linear spatiotemporal model of the fMRI response, which is a reasonable approximation over a wide range of spatio‐
temporal conditions [94–96]. The neuronal model is estimated by finding the model parameters that best predict the
fMRI measurements. (A) The pRF modeling analysis is applied to all voxels (1:n) within the defined region of interest
(ROI; e.g., occipital lobe, V1). (B) Multiple models of the expected average receptive field of the neuronal population
may be used. Most commonly, a two-dimensional Gaussian is estimated, which is defined by three parameters, x, y,
and σ, where (x, y) denotes the pRF center within the visual field, and σ is the Gaussian spread (i.e., pRF radius). Note
that these parameters are stimulus-referred in degrees of visual angle. (C) The example moving bar stimulus com‐
posed of a black and white moving checkerboard pattern moves systematically across visual space. (D) The overlap
between the pRF and effective stimulus is determined. (E, F) Next, the predicted pRF response is calculated for a given
pRF model and effective stimulus location. The time series model prediction (F) is estimated by convolving the pRF
activation with a model of the hemodynamic response function (HRF) as in (E) [94, 97]. The goodness-of-fit is estimat‐
ed by computing the residual sum of squares (RSS) between this prediction and the data (black dots) (G). (H) 100,000
different fMRI time series predictions are iteratively tested by varying the pRF model parameters across a wide range
of plausible values (e.g., locations across visual space covered by the stimulus; varying pRF sizes). Ultimately, the opti‐
mal pRF parameters (x, y, σ) are found for each voxel independently by minimizing the RSS using a two-stage, coarse-
to-fine search. Adapted from Figure 2 in [92].
2.1.1. Traveling wave retinotopy
Developed in the 1990s, TWR is still the primary fMRI paradigm used to measure early VFMs
like V1–3 (Figures 1 and 2) [13, 15, 87, 91, 93]. This technique uses two types of periodic stimuli
that move smoothly across a contiguous region of visual space to measure the orthogonal
dimensions of polar angle (i.e., “around the clock”) and eccentricity (i.e., center to periphery;
Figure 5). These stimuli are typically composed of a set of high-contrast, flickering checker‐
board patterns that are designed to maximally stimulate primary visual cortex and generally
elicit an fMRI signal modulation on the order of 1–3% (Figure 2A). This modulation is typically
15–20 standard deviations above the background noise. Each voxel’s preferred polar angle
representation is measured by a rotating wedge stimulus, which extends from the central fovea
to more peripheral regions and covers a small section of polar angles (Figure 6C, central
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inset). This wedge stimulus revolves either counterclockwise or clockwise in discrete steps
around the central fixation point, successively stimulating distinct polar angle representations
of visual space [3]. Each voxel’s preferred eccentricity representation is measured by an
expanding ring stimulus, which expands in discrete even steps between the central fovea and
the periphery of the visual field (Figure 6B, central inset). These functional data are represented
as color-coded overlays on anatomical data that demark the voxel’s preferred polar angle or
eccentricity (Figure 6B and C). The accurate delineation of VFMs relies upon the measurement
of these two, orthogonal dimensions—polar angle and eccentricity, which produce a unique
mapping between a location in visual space and the preferred responses of the neurons within
a single voxel in cortex. If only a single measurement is obtained (e.g., of only polar angle or
only eccentricity), the representation in cortex could only be associated with a wide section of
visual space and would not lead to the correct definition of VFM boundaries (Figure 5) [3].
Figure 4. White/gray matter segmentation for young, healthy aging, and mild Alzheimer’s disease subjects. Each
panel is a T1-weighted 3D MPRAGE image showing a sagittal slice near the midline of the brain. Green-colored over‐
lay represents white matter identified by an automated algorithm [104] and adjusted by hand-editing to minimize seg‐
mentation errors [1, 3, 92]. White regions below the green overlay represent unsegmented white matter within the
cerebellum. Gray matter is shown as the gray regions along the surface of the green overlay and adjacent to the black
cerebral spinal fluid (CSF; black regions within the skull). Middle inset displays approximate anatomical directions. CaS:
calcarine sulcus; POS: parietal-occipital sulcus. (A) Left hemisphere of healthy young subject. (B) Left hemisphere of
healthy aging subject. (C) Left hemisphere of a subject with mild Alzheimer’s disease (AD-S2). (D) Right hemisphere
of a second subject with mild Alzheimer’s disease (AD-S1). Note how AD-S1’s anatomy is relatively intact, but the vis‐
ual field map measurements from this subject shown in Figure 12 are perceptibly abnormal. Also compare the striking‐
ly increased CSF-filled space in this T1 image of AD-S2 to the relatively normal visual field map organization for this
subject in Figure 12. Data were adapted from [36, 37].
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Figure 5. Two orthogonal gradients are required to define a cortical field map. (A)Left: The graph demonstrates
measurements of three stimulus values—1: low (L, red); 2: medium (M, green); 3: high (H, blue)—for one sensory di‐
mension (e.g., eccentricity). Right: The graph demonstrates measurements of three stimulus values—1: low (L, orange);
2: medium (M, aqua); 3: high (H, purple) for a second sensory dimension (e.g., polar angle). Middle: Schematic of the
orthogonal gradients defining a cortical field map shows how measurements of the cortical representation of dimen‐
sion 2 change along measurements of the representation of a single value of dimension 1, and vice versa. (B) Diagrams
demonstrate how a single set of orthogonal gradients (one for each dimension) defines a single cortical field map.
Black dotted lines demark the edge of the gradient representations. (C) Diagrams here demonstrate how a reversal in
the dimension 1 gradient representations (left) divides up the single representation of the dimension 2 gradient (right)
into two cortical field maps (middle). Yellow dotted lines demark a boundary defined by a gradient reversal, and black
dotted lines again denote the edge of the gradient representations. A reversal in the dimension 2 gradient representa‐
tions would similarly divide up a single representation of the dimension 1 gradient (not shown). (D) Cloverleaf cluster
organization of multiple cortical field maps. Left: Schematic of an example macrostructural organization of dimension
1 (e.g., eccentricity) across a region of the cortical surface, with low (red) to medium (green) to high (blue) stimulus val‐
ues represented in concentric circles. Right: Schematic of an example macrostructural organization of orthogonal di‐
mension 2 (e.g., polar angle) across the same region of the cortical surface, with low (orange) to medium (aqua) to high
(purple) stimulus values represented in wedges running “around the clock”. Middle: Schematic shows the four cortical
field maps defined by these orthogonal gradients and arranged in a cloverleaf cluster [3, 111–113]. Black dotted lines
demark the edge of the gradient representations. Yellow dotted lines demark boundaries defined by a gradient rever‐
sal. For additional discussions, see [1, 3, 88].
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Figure 6. Visual field map measurements in healthy young and aging subjects. The images show example measure‐
ments of VFMs V1, V2, V3, and hV4 from a healthy young adult’s left hemisphere (top row) and from a healthy aging
adult’s left hemisphere (bottom row). (A) Cortical locations of VFMs (black lines) are show on 3D renderings of each
subject’s left hemisphere. Central inset shows the approximate location of the cropped sections of the hemispheres. For
cortical surfaces, dark gray represents sulci, and light gray represents gyri. “*” denotes the approximate location of the
occipital pole; CaS: calcarine sulcus. (B, C) Flattened views of the cortical surfaces surrounding CaS are shown for the
measurements of eccentricity (B) and polar angle (C) in each subject. The pseudocolor overlay on each flattened section
of cortex signifies the location in visual space that creates the highest activity at each cortical position (see colored leg‐
end insets, middle). The wedge and ring stimuli each maximally spanned the central 11° radius of visual space. For sim‐
plicity, cortical representations are only shown for V1, V2, V3, and hV4—the VFMs of interest. Also note that
functional data are only shown for voxels with a strong response at a coherence ≥0.20. Flattened renderings are scaled
to the same size (see 1 cm scale bar, middle inset). Approximate anatomical directions for the flattened representations
are shown in the central inset. Data were adapted from [36, 37].
The term “traveling wave” arises from the repeating pattern of cortical activity that is activated
from one end of the VFM to the other along iso-angle or iso-eccentricity lines in response to
these periodic stimuli (Figure 2B) [87, 91]. Thus, the time, or phase, of the peak modulation
induced by the stimulus varies smoothly across the cortical surface. This phase defines the
most effective stimulus eccentricity (i.e., ring) and polar angle (i.e., wedge) to activate that
region of cortex, giving TWR its description as “phase-encoded retinotopy” (Figure 2D). This
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paradigm only produces activity in regions that are retinotopically organized and is excellent
for measuring early VFMs such as V1, V2, and V3.
In neuroimaging experiments, cortical activity driven by a particular stimulus is typically
differentiated from unrelated activity and noise by setting well-defined statistical thresholds
[94]. The statistical threshold for cortical activity arising from the TWR paradigm is commonly
determined by coherence, which is equal to the amplitude of the blood-oxygen-level-depend‐
ent (BOLD) signal modulation at the frequency of stimulus presentation (e.g., six stimulus
cycles per scan), divided by the square root of the power over all other frequencies except the
first and second harmonics. Note that the activity must be correlated with the stimulus
modulation frequency; unrelated activity at other frequencies is not included in the coherence
measure. For each stimulus condition (e.g., wedge or ring), each voxel is independently
assigned a coherence value, which denotes the strength of the BOLD response of that voxel
for that particular stimulus (Figure 2C). Only voxels with a coherence above a chosen threshold
—typically a coherence of 0.15–0.30—are further evaluated to determine the organization of
cortical visual-spatial representations into specific VFMs [1, 3].
2.1.2. Population receptive field modeling
A newer method of measuring VFMs called population receptive field (pRF) modeling has
been introduced not only for measurements of early visual cortex (e.g., V1–3), but also to
improve measurements of the visual-spatial organization of higher-order regions that contain
larger RFs (Figures 1 and 3) [92]. This model relies on the fact that the population of RFs in
each voxel of retinotopically organized regions of cortex is expected to have similar preferred
centers (i.e., location in visual space driving the peak neural responses) and sizes (i.e., the
degrees of visual angle driving significant neural responses), allowing their combined pRF to
be estimated as a single, two-dimensional Gaussian RF (Figure 3B). The pRF method does not
require two distinct stimuli to measure orthogonal dimensions of visual space as in TWR, but
can use any stimulus that systematically traverses the entire field of view. Most commonly in
current measurements, this is a moving bar composed of the same checkerboard pattern with
neutral gray blocks inserted at a nonstimulus frequency (Figure 3C). The neutral gray blocks
allow for an estimation of a voxel’s response to any visual stimulus versus just the preferred
visual stimulus, which is necessary for the accurate measurement of pRF sizes.
For the first part of the analysis, the pRF model generates a database of many possible pRF
centers and sizes within the field of view covered by the stimulus. The analysis then convolves
the standard hemodynamic response function (HRF) with each of the possible pRFs (Fig‐
ure 3E). Lastly, a least-squares fitting method is used to iteratively test the actual data collected
against each of the possible pRFs for each voxel independently. The best-fit pRF position and
size is then allocated as the pRF parameters for that voxel. As in TWR, further analysis is only
performed on voxels with responses above a specific threshold of variance explained—which
can be converted to coherence—as determined by the model are included for further analysis
(for additional discussions, see [1, 3, 92]).
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2.1.3. VFMs are defined using data from individual subjects
It is vital to correctly localize common functional areas across subjects in order to then study
which specific computations are carried out by each area and how these functions change with
damage and disease; however, the size of functional regions across the cortical surface varies
significantly across individuals, complicating measurements across subject groups [14, 92, 98–
102]. The surface area of primary visual cortex (V1) can differ across subjects by a factor of 3
or more; this variation in VFM size is independent of the total brain size [14]. Consequently,
the position of each VFM with respect to the underlying structural anatomy varies across
individuals. In addition, the amount of variation tends to increase from V1 to regions of visual
cortex involved in higher-order computations (e.g., object recognition). Therefore, the common
fMRI approach of averaging measurements across subjects does not work in the case of VFM
data, as this approach will problematically blur the VFM boundaries to an unusable degree
and may even destroy all traces of VFM organization in some regions [3]. Likewise, standar‐
dized brain-template coordinates (e.g., Talairach or Montreal Neurological Institute—MNI—
coordinates) cannot be used to accurately estimate the position of any VFMs beyond area V1
in group-averaged or individual-subject data. Furthermore, issues like cortical degeneration
introduce even greater variability into the match between cortical function and structure. The
only accurate approach is to measure VFMs in individual subjects. Functional or structural
measurements from each VFM—each region of interest (ROI) —can be obtained from indi‐
vidual subjects and then averaged across the subject group by VFM.
For analysis of such functional imaging data for individual subjects, several neuroimaging
software packages are available. We use a signal-processing, Matlab-based software package
called mrVista, which was originally developed by the Wandell lab at Stanford University and
is now commonly available for neuroimaging analysis (http://white.stanford.edu/software/)
[103, 104]. Using this software, each subject’s cortical white matter is determined—“segment‐
ed”—in that subject’s high-resolution anatomical scan, first with an automated algorithm and
then by hand-editing to minimize errors for individual-subject analyses (Figure 4) [104]. Then
a 3–4 mm layer of gray matter is automatically formed arising from the segmented white matter
surface. Only data drawn from this identified gray matter are analyzed, in order to reduce
extraneous measurements arising in the white matter or noise outside the head. The gray
matter of the cortical sheet can then be visualized in three dimensions or as a flat sheet to allow
analysis of functional activity within the sulci. For analysis of the functional data, linear trends
are removed from the time series during preprocessing. Individual scans are inspected for
motion artifacts; issues with motion between individual scans or across scan sessions can be
corrected using mutual-information algorithms [105]; however, motion-correction algorithms
should not be routinely applied if not needed, as they themselves may create artifacts. Once
the preprocessed functional dataset is registered to the high-resolution anatomical scan, the
VFM activity can be viewed along the cortical sheet to allow for optimal definition of VFM
boundaries (e.g., Figures 5 and 6; for detailed discussions, see [1, 3, 88]). Importantly, we never
apply spatial smoothing to the data, as smoothing will destroy key details of VFM organiza‐
tion, much like averaging data across subjects.
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The description of a cortical “map” is frequently used nonspecifically for topographical
gradients or other related cortical representations; however, it is advantageous for research
into visual processing to explicitly define a “visual field map” in accordance with very exact
criteria: (i) a VFM comprises two (or more) orthogonal, nonrepeating topographical represen‐
tations of fundamental sensory dimensions (e.g., eccentricity and polar angle); (ii) each of these
topographical representations must be organized as an generally contiguous, orderly gradient;
(iii) each VFM should represent a substantial portion of sensory space (e.g., a hemifield of the
visual field); and (iv) the general features of each VFM should be consistent across individuals
(Figure 5) [1, 3, 13, 15, 88, 106–111]. For additional discussion, see A Brief Primer on Cortical
Field Mapping in the supplemental material of [88].
2.2. Characteristics of V1, V2, V3, and hV4 in healthy young adults
Three VFMs known as V1, V2, and V3 occupy the medial wall of occipital cortex in humans
and participate in the first stages of visual processing (for detailed reviews, see [1, 3]). Each
represents a full hemifield of the opposite—i.e., contralateral—visual field in each hemisphere;
the left hemisphere VFMs represent the right visual field, and vice versa (Figure 6).
V1 is very reliably located along the calcarine sulcus, bounded on either side by the unique
split-hemifield representations of V2 and V3 on the cuneus and lingual gyri. V1, V2, and V3
each contain a representation of the center of visual space located at the occipital pole.
Increasingly more peripheral representations form complete eccentricity gradients extending
into more anteromedial cortex forming complete eccentricity gradients (Figure 6A and B; e.g.,
[1, 3, 13, 15, 91]). The position at which the central—i.e., foveal—representations of these three
VFMs come together at the occipital pole is called the foveal confluence [114]. The boundaries
between each map are delineated by reversals in polar angle gradients (Figure 6A and C). The
polar angle gradient of V1 represents a contiguous hemifield of visual space. In contrast, the
polar angle representations of V2 and V3 each consist of a split-hemifield representation (i.e.,
a quarterfield of visual space). The separate quarterfield sections are denoted by their positions
ventral or dorsal to V1 (e.g., V2d, V2v, V3d, and V3v). For each of these three VFMs, the upper
visual quarterfield is represented on the ventral surface, and the lower visual quarterfield is
represented on the dorsal surface. The V2 and V3 quarterfields each meet at the fovea, but are
otherwise separate [3]. Due to their relatively consistent anatomical locations and unique
concentric organization, these three VFMs form the easiest landmarks to be identified in visual
field mapping analyses [13–15, 87]. An additional VFM is adjacent to V3v along the ventral
occipital surface: human V4, designated hV4 because of the unclear homology to macaque V4
[106]. The eccentricity representation of hV4 merges with the foveal confluence of V1, V2, and
V3, and the polar angle representation moves smoothly from the boundary at the upper visual
field representation of the V3v quarterfield into a full hemifield representation.
V1 is labeled as primary visual cortex, because it receives direct input from the retinal-thalamic
pathway and is the first place along this pathway where information from the two eyes is
combined [115]. In addition, V1 is an important site of initial basic calculations for such visual
processing as orientation, color, and motion [116–120]. Beyond V1, perceptual calculations
become more specialized, with V2 subserving relatively simple color and form perception and
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V3 more selectively supporting motion processing [118, 119, 121–124]. hV4 serves as the next
stage of the V1–V2 processing pathway with specialized neuronal populations for somewhat
more complicated color and form visual perception [106, 125, 126]. Damage to part of the retina
or V1 produces a complete loss of visual perception within the region normally processed by
the damaged tissue in most cases [9], while damage to VFMs beyond V1 can produce more
selective visual deficits like loss of color vision (i.e., achromatopsia; damage to hV4) or loss of
motion perception (i.e., akinetopsia; damage to hMT+) [121, 127–131].
3. Specific changes occur in early visual cortex during otherwise healthy
aging
In order to carefully evaluate alterations of visual cortex in the age-related neurodegenerative
destruction of AD, we must investigate what changes occur across visual cortex during healthy
aging [57, 132, 133]. To do so, studies have typically measured healthy visual aging in subjects
over the age of 55 with no known age-related diseases or specific, clinically recognized deficits
in vision. Major lesions along the retino-cortical visual pathways are not expected to occur in
healthy aging, unlike in AD, but subtle retinal and cortical lesions as described below likely
contribute to the variations in visual behavior associated with aging.
Lesion studies in young adult human subjects and animal models have outlined general
expectations for changes in cortex that underlie the behavioral deficits arising from the loss of
or alterations to the retina or visual pathways (Figure 7). Consider a retinal lesion that destroys
function in the center of vision (i.e., the fovea). In this case, neurons with a pRF entirely within
the cortical region to which the lesion projects (i.e., the lesion projection zone, LPZ) will be
silenced, causing the cortical activity—and thus the corresponding BOLD signal—to drop to
near zero and the distribution of the central eccentricity representation across the surface area
of a VFM to shift to be more peripheral, as activity in the foveal representation would be lost
(Figure 7A and B, top row). A second set of neurons would have RF centers located within the
LPZ, but would have some of the spread of the pRF remain activated by still-healthy retinal
regions. Here, the BOLD signal may drop somewhat but not completely, the surface area
distribution would still shift toward the periphery, and the pRF centers of these neurons would
also be measured as shifting toward the periphery (Figure 7A and B, middle row). Finally, a
third set of neurons would have pRF centers outside of the LPZ, but would have some of the
spread of the pRF still within the LPZ. Measurements of these neurons would likely show little
drop in BOLD signal, a small shift of surface area distributions to the periphery, and also a
small shift of pRF centers toward the periphery (Figure 7A and B, bottom row).
Anatomical and neuroimaging measurements from the few studies to date examining VFM
changes in healthy aging have demonstrated several such changes in aging visual pathways
that may contribute to such age-related behavioral changes as a decline in visual acuity, deficits
in contrast sensitivity, and changes in color vision and visual-spatial attention. Next, we
examine how such cortical changes may contribute to these healthy-aging behavioral deficits.
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Figure 7. Schematic of the predicted effects of a retinal or cortical lesion on receptive field responses. (A) Solid black
disks and the black-outlined teal circles around them indicate the preferred center and spread of a neuron’s receptive
field, respectively. Each row represents neurons with preferred centers at one specific eccentricity under normal condi‐
tions. (B) The gray-shaded regions indicate the lesion projection zone (LPZ) arising from retinal or cortical neuronal
loss. The interaction of the LPZ with a neuron’s receptive field is expected to shift the receptive field center more pe‐
ripherally relative to normal conditions, as indicated by the black arrows. Top: RFs of these neurons are completely
obscured by the LPZ. Middle: RFs of these neurons are partially obscured by the LPZ, and the RF centers fall within the
LPZ. Bottom: RFs of these neurons are partially obscured by the LPZ, and the RF centers fall outside the LPZ. For addi‐
tional discussions, see [8, 9, 12, 16].
3.1. Reductions in cortical activity
A change in cortical activity, whether from a change in peripheral inputs to a particular region
(Figure 7B, top row) or from general changes in cortical responsivity with aging, is a likely
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component of such aging deficits as a decrease in effective peripheral vision and problems
with color discrimination. Given the increase in our knowledge of the role of certain cortical
regions with specific behaviors, it is particularly interesting to examine changes in the level of
activity of individual VFMs between healthy young adult and aging subjects.
3.1.1. Shrinkage of the useful field of view
Decrease in sensitivity across the visual field and a shrinkage of the useful field of view have
been measured in behavioral studies of healthy aging subjects, with greater impairments in
peripheral vision [28, 29, 38, 134]. The useful field of view is defined as the visual area in which
information can be acquired while the eyes are held steady on a single fixation point. Within
the useful field of view, a subject is able to detect, identify and discriminate visual stimuli
without making an eye movement away from central fixation.
Measurements of visual search, in which the subject seeks a visual target (e.g., a single “T”)
hidden among distractors (e.g., many “L”s) demonstrated that there is a reduction as a function
of increasing age in the size of the visual field used in the visual search task [38]. This reduction
in the useful visual field size arises from a decrease in useful peripheral vision, but can be seen
in healthy aging subjects without any clinical conditions affecting the optics of the eye.
Although relative lens density increases with age and average pupil size is reduced, these
changes do not account for the loss of useful peripheral vision or for the decrease in visual
field sensitivity, which suggests that age-related visual field sensitivity changes are primarily
due to neural losses rather than preretinal issues.
Evidence for how these changes may arise in cortex has been found with fMRI measurements
of the BOLD signal modulation (measured as coherence) in early VFMs. In our recent study
that used fMRI with pRF modeling to measure healthy aging VFM characteristics, the coher‐
ence of the peripheral 7–10° representation in V1 was found to be significantly lower in aging
subjects than in youthful subjects (Figure 8A) [36, 37]. No significant differences in more
peripheral regions of V2, V3, or hV4 were measured between subject groups (Figure 8B–D),
so it is possible that the decrease in V1 alone—the primary visual cortex through which the
majority of visual inputs pass—is sufficient to drive the behavioral changes. Due to the
difficulty in setting up an fMRI paradigm to measure the visual periphery beyond 15–20°, no
studies have yet investigated whether additional changes occur in this region across these
VFMs.
Similarly, electrophysiology measurements of normally aging macaque monkeys have shown
a significant decrease in the response-to-noise ratio and an increase in the neural-response
variability in V1 and in the motion-selective medial temporal area (MT, also known as V5) in
aging macaque monkeys [43]. These changes in cortical signals have been suggested to possibly
arise from a degradation of inhibitory intra-cortical circuits in aging. With such degradations,
the selectivity of particular neurons likely decreases, leading to greater activity arising from
noise in a particular visual pathway and a consequent decrease in accurate signal-to-noise
visual discrimination. In addition, anatomical studies of the visual pathway changes in normal
aging humans demonstrate a decline in the retinal-nerve-fiber-layer thickness [46, 54] and a
loss of retinal rod photoreceptors [49, 50, 53], both of which could cause a decrease in coherence
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in peripheral V1 and subsequent VFMs as well as a reduction in the general visual field
sensitivity.
Figure 8. Average measurements of BOLD response in coherence for visual field maps in young, healthy aging, and
mild Alzheimer’s disease subjects. Blue lines represent data from healthy young subjects, red lines represent data
from healthy aging subjects, and green lines represent data from AD subjects. Each line represents data measured in
individual subjects and then averaged by iso-eccentricity band across hemispheres. Regions for each measurement
shown to be significant are shown along the x-axis with shaded gray regions for comparisons between aging and
youthful subjects and solid black lines for comparisons between AD and aging subjects. Dotted black lines represent
regions shown to be marginally significant for comparisons between AD and aging subjects. Error bars indicate S.E.M.
(A) V1; (B) V2; (C) V3; (D) hV4. Note the consistency for the youthful subjects and the somewhat greater variability for
the healthy aging subjects. Also note both the decreased coherence and increased measurement variability for the AD
subjects. Data were collected from [36, 37, 39].
3.1.2. Problems with color discrimination
Aging subjects frequently demonstrate losses in color discrimination—the ability to tell color
hues apart—especially along the blue-yellow axis. While these issues can be partially attrib‐
uted to changes in the aging lens [35] or to a loss of retinal S-cone (short wavelength) photo‐
receptors, which have a peak selectivity for shorter wave lengths of light [29, 30, 135], growing
evidence points to additional concurrent neural changes underlying these deficits (e.g., [27,
37, 136]). For example, after corrections for preretinal losses, the decrease in the sensitivity of
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S-cone pathways was found to be approximately 0.09 log units per decade in central vision,
and these reductions became larger with measurements across the peripheral visual field to
30° [27]. M-cone (middle wavelength) and L-cone (long wavelength) pathways showed similar
but not as severe age-related losses, with a decrease per decade of approximately 0.06–0.70 log
units. Only some of this loss can be attributed to retinal changes, with the rest arising in central
visual pathways.
Along these lines, fMRI measurements of cortical activity suggest that changes in the cortical
color processing pathways may reflect issues with S-cone sensitivity and may further contrib‐
ute to problems with color discrimination in normally aging subjects. Interestingly, our
measurements of the BOLD coherence in hV4 demonstrated an increase in cortical activity
over the central 1–7° of eccentricity in healthy aging relative to youthful subjects (Figure 8D)
[37]. This coherence increase was consistent across all hemispheres in all subjects. It is possible
that aging changes specific to the ventral visual color and form pathway involving V1, V2, and
hV4 culminate in increased hV4 activity. In addition, although the total surface areas of V1–3
spanning the tested fields of view did not significantly change with age, the total surface area
of hV4 was significantly smaller in the healthy aging subjects, perhaps due to losses in color
pathway inputs (Figure 9) [36, 37, 39, 45]. Similar increases in occipital activity in healthy aging
subjects in studies of visual working memory have been suggested to be a sign of a form of
compensatory cognitive activity [55]; perhaps the increased hV4 activity in healthy aging
similarly reflects a cognitive attempt to compensate for the reduced size of hV4 and/or for
issues with color processing elsewhere in the visual pathways.
Figure 9. Total surface area measurements for visual field maps in young, healthy aging, and mild Alzheimer’s dis‐
ease subjects. Blue shading again indicates youthful subjects, red shading indicates normal aging subjects, and green
shading indicates AD subjects. Total surface area in mm2 for each visual field map was averaged across the individual
subject measurements within in each group. “*” marks statistically significant differences (p < 0.05). Error bars indicate
S.E.M. Data were collected from [36, 37].
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3.2. Decreases in the cortical magnification of foveal representations
Cortical magnification is a common property of sensory systems that may arise from the
increased cortical representation of a particular region of sensory space important for behavior.
A change in the size of a specific part of a cortical representation between species or subject
groups would suggest a related change in the functional properties of that region of cortex and
possibly in behavior. For example, if the foveal representation of V1 is significantly reduced
in extent for a particular patient group, then it is likely that there is a difference between those
patients’ central visual processing and that of healthy subjects with normally sized foveal
representations (e.g., [8, 10, 12, 36, 37]).
Current measurements of cortical magnification usually consider only one dimension of visual
space (e.g., position along eccentricity axis) and disregard the other dimension (e.g., position
along polar angle axis) [14]. Thus, the cortical magnification factor as a function of position
along the eccentricity axis does not reflect the magnification of representation along an iso-
eccentricity line (i.e., across polar angles). We have recently altered such measurements to
provide a measure that takes this “width” across polar angles into account by determining the
surface-area-percent distributions for each VFM [3, 36, 37, 88, 111]. This is a measurement of
what percentage of the total surface area of a VFM (spanning the tested field of view) is the
surface area of the representation of a 1° band of eccentricity. As in cortical magnification,
changes in the surface-area-percent distribution within a VFM can propose likely changes in
function; for example, decreases in the foveal surface area may correlate with deficits in central
vision (Figure 7B).
3.2.1. Decline in visual acuity
Our static visual acuity determines the smallest detail that we can distinguish in a stationary
visual target. Such acuity has been shown to decline after 50 years of age, even in healthy aging
subjects with good visual correction through glasses or contact lenses [24, 29, 41, 50, 137]. This
loss in visual acuity is exacerbated by low contrast or low luminance in the visual scene [29].
As we rely on our central, foveal vision for our highest acuity, changes in foveal representations
would be expected as part of a cortical contribution to this age-related decline in visual acuity.
Our pRF measurements of cortical surface area demonstrated just such a change, measuring
a significant decrease in the foveal surface-area-percent distributions of early VFMs V1–hV4
for healthy aging subjects relative to young subjects (Figure 10, red and blue lines, respectively)
[36, 37]. A second study by Crossland et al. [39] similarly measured a comparable decrease in
the proportion of V1 representing the fovea, by comparing foveal eccentricity activations
within polar angle measurements. These aging foveal-representation decreases are consistent
with the decline in visual acuity seen normally in aging [24, 29, 41, 50, 137]. These measure‐
ments of foveal changes are unlikely to have arisen from unstable eye position, as Crossland
et al. [39] demonstrated that aging has no effect on fixation stability, and models of improper
fixation do not predict such results [12, 138]. Such a decrease in the size of the aging foveal
representations across multiple early VFMs would be expected to lead to a loss in the resolution
of cortical processing of visual information within the fovea, thus diminishing visual acuity.
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Figure 10. Surface area distribution as the percentage of total surface area. Graphs display average surface-area-per‐
cent-distribution measurements for visual field maps in young (blue lines), healthy aging (red lines), and AD (green lines)
subjects. Each line represents data measured in individual subjects and then averaged by iso-eccentricity band across
hemispheres. Regions for each measurement shown to be significantly different are shown with shaded gray regions
for comparisons between aging and youthful subjects (A) V1; (B) V2; (C) V3; (D) hV4. Note the relatively increased
foveal distribution in the youthful subjects, and the relatively increased peripheral distribution in AD subjects. Error
bars indicate S.E.M. Data were collected from [36, 37].
3.2.2. Deficits in spatial and temporal contrast sensitivity
Spatial contrast is the difference in luminance (i.e., brightness) or color that makes an object
within a visual scene distinguishable from the rest of the scene. Spatial contrast sensitivity,
then, is a measure of a subject’s ability to distinguish bright and dark aspects of a scene. This
ability is a very important part of visual function, especially in situations of low light or glare
(e.g., as in night driving), when the contrast between objects and their background is reduced.
Spatial contrast sensitivity is commonly measured by a patient’s ability to distinguish light
and dark gratings, and age-related declines are most notable for gratings of intermediate and
high spatial frequency [139, 140]. This problem cannot be eliminated by optimal lens correction
[141, 142] or by elevated luminance [18, 141]. Along these lines, Elliot et al. [19, 33] demon‐
strated that the decrease in spatial contrast sensitivity at medium and high spatial frequencies
with increasing age is mostly due to retinal and cortical changes rather than optical changes
in the eye. The decreases in the surface-area-percent distributions of the V1–hV4 foveal
representations in healthy aging compared with young adult subjects are likely to play a role
in these spatial-contrast-sensitivity impairments, in addition to the decline in visual acuity
described above (Figure 10) [36, 37, 39]. As the cortical territory devoted to central visual
processing decreases, fewer neurons will be available to subserve behavioral discrimination
of differences in spatial contrast.
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The visual system also is sensitive to temporal contrast; temporal contrast sensitivity is a
measure of the light-level difference (i.e., contrast modulation) required for an observer to be
able discriminate a light source as flickering versus steady. Temporal contrast sensitivity is
typically measured using a spatially uniform, randomly flickering stimulus. If the stimulus
changes too slowly, an observer cannot detect the change, and if the stimulus changes too
quickly, it is seen as a steady rather than flickering image. Similar to the problems with spatial
contrast, aging subjects have decreased temporal contrast sensitivity at intermediate and high
temporal frequencies [22, 25], as well as problems with motion discrimination [21, 32]. As
human V1 and V3 have been implicated in motion processing [118, 143], the decreased foveal
surface areas of aging V1 and V3 may similarly play a role in these temporal-contrast-
sensitivity and motion-discrimination deficits (Figure 10A and C) [141].
3.2.3. Difficulties with visual-spatial attention
Visual-spatial attention is our ability to focus on a specific stimulus in our visual environment.
When we look at a visual scene, our attention is drawn to a handful of locations that contain
critical pieces of information. Normal visual processing relies on accurate and efficient use of
visual-spatial attention, calibrated over a lifetime of visual experiences. Deficits in visual-
spatial attention are associated with many neurological and neuropsychiatric disorders (e.g.,
hemispatial neglect [144], autism [145], schizophrenia [146]), and subtle problems with
attention are thought to contribute to issues in healthy aging such as increased difficulty with
driving [147, 148].
Measurements in macaque and human visual areas V1, V2, and V4 have demonstrated neural
mechanisms in these VFMs possibly subserving selective visual-spatial attention [125, 149–
151]. In humans, the significantly smaller surface areas of V2 from 1° to 7° and from 0° to 3° in
V1 and hV4 in aging subjects likely denote issues in the processing of high acuity central vision
in these regions. Such changes could then contribute to these deficits in visual-spatial attention,
(Figure 10A, B, and D). In addition, the shrinkage of the useful field of view in aging described
above may arise from issues correctly deploying visual-spatial attention to the periphery [28,
29, 31, 134].
3.3. Increases in the size of population receptive fields (pRFs)
As seen for cortical magnification, the receptive field sizes of sensory neurons suggest
sensitivity to key aspects of sensory space. Smaller receptive fields can produce a higher
resolution of sensory processing and suggest improved behavioral discrimination. For VFMs
V1–hV4 in healthy subjects, the foveal representations are relatively magnified and also
contain the smallest receptive fields [3, 14, 36, 92]. As inputs to visual areas are degraded, as
from lesions to the retina or earlier visual pathways, these receptive fields tend to change in
size (e.g., [8, 10, 12, 16, 152]). Changes can either be an increase in size, as, for example, normal
lateral inhibition—which tends to refine and narrow receptive fields—is lost, or be a decrease
in size, as inputs to that receptive field drop out (Figure 7B).
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3.3.1. Enlargement of foveal pRFs likely contributes to many of the behavioral deficits associated with
healthy aging
Further cortical changes that may contribute to the decreased visual acuity in normal aging
include the differences in pRF sizes measured across the early VFMs of healthy aging subjects
(Figure 11) [19, 26, 33, 36, 50]. Significant increases in pRF sizes are present in the foveal
representations across V1, V2, V3, and hV4 from 0° to at least 3° of eccentricity [36, 37]. The
∼2° foveal pRF size in the V1 of aging subjects is near that of the more peripheral pRF sizes
(e.g., 5–7° of eccentricity) in young adults [36, 92]. Similarly, V2, V3, and hV4 of the healthy
aging subjects contain foveal pRFs comparable in size to the pRF sizes of the more peripheral
regions of these VFMs in healthy young subjects [37]. The increased foveal pRF sizes in these
VFMs may reflect the decrease in visual acuity seen in healthy aging subjects. The decreased
foveal surface area in the VFMs of aging subjects may drive these increases in pRF sizes as a
compensatory mechanism, but we do not yet know whether such changes in pRF sizes arise
directly within these VFMs during healthy aging or reflect other variations such as loss of
retinal ganglion cells or alterations in feedback from higher-order VFMs.
Figure 11. Average population receptive field size measurements for visual field maps in young, healthy aging, and
mild Alzheimer’s disease subjects. Average pRF radius in degrees of visual angle (dva) across each visual field map is
shown for young (blue lines), healthy aging (green lines), and AD (red lines) subjects. Each line again represents data
measured in individual subjects and then averaged by iso-eccentricity band across hemispheres. Regions for each
measurement shown to be significantly different are shown with shaded gray regions for comparisons between aging
and youthful subjects and solid black lines for comparisons between AD and aging subjects. Dotted black lines repre‐
sent regions shown to be marginally significant for comparisons between AD and aging subjects (A) V1; (B) V2; (C) V3;
(D) hV4. Note the generally increased pRF sizes and variability for measurements in aging and AD subjects relative to
the youthful subjects. Data were collected from [36, 37].
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In addition, the broadening of pRF sizes in the aging foveae of these four early VFMs is also
consistent with the other behavioral deficits discussed in the sections above. Loss of resolution
through these increased foveal pRF sizes likely underlies the decrease in spatial contrast
sensitivity (Figure 11). The increased pRF sizes of aging V1 and V3 may similarly play a role
in temporal-contrast-sensitivity and motion-discrimination deficits (Figure 11A and C). With
respect to issues with color discrimination [27, 29, 30, 35], we have measured significant
differences in pRF sizes in V2 and hV4 out to 5° and 6°, respectively, as well as foveal changes
in V1 from 0° to 3° (Figure 11A, B, and D). It is possible that these greater regions of expanded
pRFs in aging subjects are associated with aging changes specific to a ventral visual color and
form pathway involving V1, V2, and hV4. Finally, V2 and hV4 both showed increases in pRF
sizes across larger foveal and parafoveal regions (Figure 11B and D). These larger pRF sizes
could reflect deficits in the proper tuning of visual-spatial attention and less ability to attend
across the entire visual field.
4. Alzheimer’s disease can present with additional changes in visual cortex
AD is characterized by progressive cognitive deficits including disturbances in memory,
language, executive function, and vision [57, 84]. Somewhat surprisingly, it is not uncommon
for visual deficits to be reported as one of the first symptoms of AD. However, despite many
descriptions of visual symptoms in AD, only a very few studies have begun to examine the
extent of changes in the organization, functionality, and connectivity of visual cortex that
underlie these visual deficits.
4.1. Patterns of neurodegeneration in the visual cortex of AD patients
AD can present with a variety of visual symptoms across subjects, from lower-level deficits
such as changes in visual acuity, contrast sensitivity, color discrimination, visual-spatial
perception, and visual-processing speed [40, 73, 85, 132, 153, 154] to higher-level deficits such
as problems in visual-spatial attention and in feature recognition of complex objects such as
faces [40, 61, 63, 65, 69, 76, 78, 155, 156]. The neuropathology of AD results in gray matter lesions
of varying density within regions of visual cortex [48, 57, 76, 84], and the visual symptoms
could be attributed in part to a random pattern of neurodegeneration across regions of visual
cortex [132]. However, there is also evidence for a more precise distribution of neurodegen‐
eration in the AD visual pathways [48, 84], with some studies showing neurofibrillary tangles
and neuritic senile plaques increasing steadily from primary to associative visual cortex and
degenerative changes in both the retina ganglion cells and optic nerves [58, 59, 64, 66–68, 70].
The role that such changes may play in the visual symptoms of AD is discussed in the following
sections.
Although AD is primarily a disorder of cortical gray matter, some studies have also shown a
decreased density of the connections through the splenium of the corpus callosum, the region
of the major interhemispheric white matter pathway that connects left and right visual cortex
[47, 79, 157]. The changes in the white matter tracts in dementia may result from Wallerian
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degeneration following retinal and cortical lesions or may be the product of a primary
neuropathological process within the white matter itself. In the first case, we expect such white
matter changes to reflect the behavioral deficits associated with the related gray matter or
retinal lesion. In the latter, the direct loss of white matter connectivity may itself further
contribute to these visual symptoms. Future studies tying functional MRI measurements of
VFM organization and function together with diffusion tensor imaging (DTI) MR measure‐
ments of white matter tracts in the same subjects should help to clarify the presence and extent
of each option in dementia with visual symptoms.
4.2. Visual deficits may arise in AD from both random and precise degenerative changes in
cortex
fMRI measurements of cortical gray matter in AD subjects point to a combination of patterns
of neurodegeneration, with some specific changes within cortical representations like VFMs
seen consistently across subjects (e.g., Figures 8–11) in addition to variable alterations in gross
Figure 12. Visual field map measurements in mild Alzheimer’s disease subjects. (A, B) Examples of VFMs V1, V2,
V3, and hV4 are shown for the left (A) and right (B) hemispheres of a single subject with mild AD (AD-S1). For clarity,
the visual responses are only shown for the VFMs of interest—V1, V2, V3, and hV4—and only voxels with a powerful
response at a coherence ≥0.20 are colored. Note the visibly smaller size of these VFMs in this subject compared to those
shown for young and healthy aging subjects in Figure 6. While the polar angle gradients still contain the expected rep‐
resentations of contralateral visual space with orderly reversals between VFMs, the eccentricity measurements, drawn
from the same fMRI scans using the moving bar stimulus, are more disorganized. For cortical surfaces, dark gray rep‐
resents sulci, and light gray represents gyri. “*” denotes the approximate location of the occipital pole. CaS: calcarine
sulcus. (C, D) Images depict the full 3D cortical renderings, approximate anatomical orientations for each hemisphere,
the color legends for the respective measurements, and the 1 cm scale bar. Note that all flattened hemispheres have
been adjusted to the same scale; scale bar is duplicated for ease of comparison. (E, F) A second set of examples is
shown for the left (E) and right (F) hemispheres from a second subject with mild AD (AD-S2). This AD subject displays
more normal VFM sizes and foveal eccentricity representations, but also has visible changes in the peripheral eccen‐
tricity representations. Other details are as described in Figure 6. Data were collected from [37].
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cortical organization (e.g., Figure 12). Measurements of both aspects of distributed neurode‐
generation in the visual pathways can be useful in the diagnosis of AD in a specific individual
and for understanding the progression this disease across cortex generally.
To date, the only neuroimaging study of VFM changes in AD patients that we are aware of is
our Brewer and Barton (2014) study [36, 37], which used fMRI and pRF modeling to measure
VFMs in a small number of patients with mild-to-moderate AD. Our results did not demon‐
strate simply a worsening of the deficits we measured in healthy aging subjects; rather, we
observed both the visual deficits we found in healthy aging and additional changes in
extrastriate VFMs (V2, V3, and hV4) unique to our AD subjects. Differences among our
measurements of the hemispheres of each AD subject were likely primarily due to individual
variations in the pattern and progression of neurodegeneration in each subject, revealed by
detailed individual-subject data analysis. In addition, there were consistent patterns of changes
across the cortical hemispheres that also likely reflected more uniform effects of AD on the
visual pathways.
These measurements both demonstrated the feasibility of examining VFM changes in patients
with dementia—despite the potentially difficult requirements of maintaining fixation and
visual-spatial attention for several consecutive minutes—and emphasized the need for such
detailed analyses in individual subjects for these types of investigations. Cortical changes seen
consistently across AD patients may underlie the visual symptoms seen early in the disease
[67] and may prove to be a useful tool for early and accurate diagnosis of AD. We review here
some of the basic trends of VFM changes in AD patients, and, as above for healthy aging
subjects, we suggest how these cortical changes may relate to specific deficits in visual
behavior.
4.2.1. Declines in visual acuity and contrast sensitivity
Psychophysical studies have observed decreases in both visual acuity and contrast sensitivity
in AD subjects beyond that expected for age-matched controls [71, 75]. In particular, psycho‐
physical measures in AD patients showed a decrease in spatial contrast sensitivity for lower
spatial frequencies than measured in the healthy aging population [40, 63]. Our measurements
of significantly decreased BOLD coherence in regions of V1 and V2, with a marginally
significant decrease in coherence in V3, could underlie these deficits (Figure 8A–C) [37].
Similarly, we found that the AD subjects significantly differed from healthy aging subjects in
terms of total surface area of V3, with a general trend for decreased total surface area across
V1–3 (Figure 9). While there were no significant differences in the surface area of V1 between
healthy aging and AD subjects, the higher variability of these measurements highlights
individual differences in neurodegenerative patterns in primary visual cortex as well as the
need for additional studies of VFMs in a large number of AD subjects. On average, our AD
subjects had no further decline in the surface-area-percent distribution of the foveal represen‐
tation from 0° to 3° than that seen in the healthy aging subjects compared to youth (Fig‐
ure 10). However, there was a trend for shifts from foveal to peripheral representations, which
could point to a variable but important loss of central visual processing.
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A striking feature of our AD measurements was the much-reduced total surface areas of V1–
hV4 in one subject (AD-S1; Figure 12A and B). The shrunken VFMs additionally displayed
very disorganized eccentricity representations with little foveal representation, likely due to
an idiosyncratic pattern of neurodegeneration around the occipital pole. It is important to note
that the polar angle representation, drawn from the same scan as the eccentricity representa‐
tion, remained normal; thus the disorganization seen in the eccentricity representations cannot
be simply attributed to a problem with that particular scan, but rather likely reflects alterations
in visual function in this individual. Such a dramatic change in early VFM sizes would be
expected to result in at least a significant decline in visual acuity and likely reflects changes in
multiple aspects of visual processing; even so, the clinical examination of visual function in
this subject reported no issues.
4.2.2. Deficiencies in color and form processing
Our measurements of VFM changes in AD were also consistent with the deficiencies in color
and form processing frequently described in AD [73, 85, 153]. As suggested by Chan et al. [153],
the degeneration of excitatory neurons in AD with the relative sparing of inhibitory inter‐
neurons in V1 may result in the color vision disorders reported by a subset of AD patients.
This process could also drive the significant decrease we observed in pRF sizes in more
peripheral hV4, a key region for color vision processing (Figure 11D). Patients with idiosyn‐
cratic foveal loss—as seen in our AD subject with greatly reduced VFM surface areas—might
also present with these deficiencies in color and form processing.
4.2.3. Problems in the visual-spatial attentional network
Finally, the commonly reported changes in visual-spatial attention in AD patients may be
related to the coherence changes we observed in V1 and V2 (Figure 8) [40, 63]. The marginally
significant decreases in pRF sizes in the periphery of V2 and V3 and the significant pRF size
decreases in the periphery of hV4 may also be involved in the deficiencies in the visual-spatial
attentional network in AD and could contribute to the shrinkage of useful visual field that is
often be even worse in AD patients than in healthy aging (Figure 11B–D) [72]. These cortical
changes again may reflect degenerative disease in the retina and optic nerves or variations in
feedback from higher-order VFMs [37]; some studies have shown that these regions contain
more lesions in mild-to-moderate AD than V1 [48, 132]. In addition, V1, V2, and V4 both have
been shown to play major roles in the visual-spatial attentional network, as described above
[125, 149–151]. Future studies will be needed to examine whether similar changes in VFMs can
be measured in the higher-order visual-spatial attention regions of parietal and frontal cortex
(e.g., [158–161]).
4.3. These visual field map measurements may be able to improve the early diagnosis of
specific types of dementia
Investigations into the early diagnosis of AD include such a wide range of methods as
biochemical markers, cognitive testing, and structural and functional neuroimaging [47, 162,
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163]. The ability to identify changes in cortical structure or function very early in the devel‐
opment of AD would increase the efficacy of treatments that stop the progression of the
neurodegeneration before a significant amount of cortex is lost [62]. Neuroimaging measure‐
ments of VFM changes in patients with mild AD may provide an avenue for such early
diagnosis, as these measurements can reveal subtle and highly detailed cortical changes using
non-invasive fMRI [37]. In addition, these measurements in individual subjects also provide
the opportunity to follow neurodegenerative changes in specific individuals over the course
of their dementia progression (e.g., [9]). Further research into VFM characteristics in AD should
include not only a larger population of AD patients, but also should examine the potential
onset of visual symptoms in patients with mild cognitive impairment (MCI), which may
provide an even earlier diagnostic tool [37, 55, 154, 164].
Disagreement also persists regarding the categorization of neurodegenerative symptoms into
specific types of dementia. We do not yet have a complete understanding of how the different
types of dementia—e.g., AD, PCA, DLB, etc.—vary with respect to the start of their associated
neurodegenerative changes. Criteria have been outlined to differentiate AD from other
dementias, but there still remains significant overlap across the symptoms associated with
each dementia (e.g., [56, 78, 85, 86, 165]). The ability to distinguish a patient’s particular type
of dementia at an early time point in the disease may be vital for the identifying the correct
treatment. Such comprehensive measurements of alterations in VFM characteristics as
discussed here may assist in this early identification and diagnosis, as the onset and severity
of changes in visual cortex are expected to follow patterns specific to each particular dementia
[37].
5. Conclusion
Systematic changes in visual cortex likely occur as part of both the normal aging process and
the pathophysiology of AD. A better understanding of the alteration of visual representations
during healthy aging would both help reveal the effects of healthy aging on visual processing
and enhance the use of age-matched controls in studies of visual symptoms in age-related
diseases [57, 132]. Our hope is that such data will contribute to earlier and more definitive
detection of these forms of dementia and a better understanding of the differences between
AD and related dementias.
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